Connect Biopharma Holdings Limited (CNTB) vs Champions Oncology, Inc. (CSBR)
A side-by-side comparison of Connect Biopharma Holdings Limited and Champions Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.95HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
CSBR
Champions Oncology, Inc.
$5.06HealthcareDelayed quote: Oct 6, 2026, 12:36 PM EDT
Total return — CNTB vs CSBR
growth of $100 · dividends reinvested · last 6yCNTB -95.1% (-39.6%/yr)CSBR -62.3% (-15.0%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CNTB CSBR
CNTB vs CSBR: by the numbers
- •CSBR is the larger company ($70M vs $60M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | CSBR |
|---|---|---|
| Forward P/E | N/A | 50.60 |
| P/S ratio | N/A | 1.16 |
| P/B ratio | 2.22 | 18.06 |
| EV / EBITDA | N/A | 264.31 |
Profitability
| Metric | CNTB | CSBR |
|---|---|---|
| Gross margin | 100.00% | 49.30% |
| Operating margin | -90740.62% | -1.72% |
| Net margin | -86687.50% | -1.87% |
| ROE | -132.16% | -29.15% |
| ROIC | -136.77% | -6.75% |
Growth (annualized)
| Metric | CNTB | CSBR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.25% |
| Total return CAGR (5Y) | -47.22% | -13.07% |
Frequently asked
- How have CNTB and CSBR total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and CSBR delivered -13.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.